These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20660071)

  • 1. Designing a long-acting human growth hormone (hGH) by fusing the carboxyl-terminal peptide of human chorionic gonadotropin beta-subunit to the coding sequence of hGH.
    Fares F; Guy R; Bar-Ilan A; Felikman Y; Fima E
    Endocrinology; 2010 Sep; 151(9):4410-7. PubMed ID: 20660071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotropin beta-subunit to the coding sequence of human erythropoietin.
    Fares F; Ganem S; Hajouj T; Agai E
    Endocrinology; 2007 Oct; 148(10):5081-7. PubMed ID: 17641000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusing the carboxy-terminal peptide of the chorionic gonadotropin (CG) beta-subunit to the common alpha-subunit: retention of O-linked glycosylation and enhanced in vivo bioactivity of chimeric human CG.
    Furuhashi M; Shikone T; Fares FA; Sugahara T; Hsueh AJ; Boime I
    Mol Endocrinol; 1995 Jan; 9(1):54-63. PubMed ID: 7539107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the 3' region of mammalian gonadotropin β subunit gene in the luteinizing hormone to chorionic gonadotropin evolution.
    Gabay R; Rozen S; Samokovlisky A; Amor Y; Rosenfeld R; Kohen F; Amsterdam A; Berger P; Ben-Menahem D
    Mol Cell Endocrinol; 2014 Feb; 382(2):781-90. PubMed ID: 24239648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunit.
    Ceaglio N; Gugliotta A; Tardivo MB; Cravero D; Etcheverrigaray M; Kratje R; Oggero M
    J Biotechnol; 2016 Mar; 221():13-24. PubMed ID: 26806490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro and in Vivo Characterization of MOD-4023, a Long-Acting Carboxy-Terminal Peptide (CTP)-Modified Human Growth Hormone.
    Hershkovitz O; Bar-Ilan A; Guy R; Felikman Y; Moschcovich L; Hwa V; Rosenfeld RG; Fima E; Hart G
    Mol Pharm; 2016 Feb; 13(2):631-9. PubMed ID: 26713839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant thyrotropin containing a beta-subunit chimera with the human chorionic gonadotropin-beta carboxy-terminus is biologically active, with a prolonged plasma half-life: role of carbohydrate in bioactivity and metabolic clearance.
    Joshi L; Murata Y; Wondisford FE; Szkudlinski MW; Desai R; Weintraub BD
    Endocrinology; 1995 Sep; 136(9):3839-48. PubMed ID: 7544273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of O-linked glycosylation in the chimera consisting of alpha-subunit and carboxyl-terminal peptide of the human chorionic gonadotropin beta-subunit is affected by dimer formation with follicle-stimulating hormone beta-subunit.
    Furuhashi M; Suganuma N
    Endocr J; 2004 Feb; 51(1):53-9. PubMed ID: 15004409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albutropin: a growth hormone-albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys.
    Osborn BL; Sekut L; Corcoran M; Poortman C; Sturm B; Chen G; Mather D; Lin HL; Parry TJ
    Eur J Pharmacol; 2002 Dec; 456(1-3):149-58. PubMed ID: 12450581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxy-terminal region of the beta-subunits of luteinizing hormone and chorionic gonadotropin differentially influence secretion and assembly of the heterodimers.
    Muyan M; Furuhashi M; Sugahara T; Boime I
    Mol Endocrinol; 1996 Dec; 10(12):1678-87. PubMed ID: 8961276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a recombinant bifunctional protein from a chimera of human lutropin receptor and human chorionic gonadotropin beta-subunit.
    Hao M; Rathnam P; Saxena B
    J Reprod Immunol; 2004 Oct; 63(2):123-35. PubMed ID: 15380943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a therapeutic protein by fusing it with two fragments of the carboxyl-terminal peptide of human chorionic gonadotropin β-subunit in Pichia pastoris.
    Wang B; Wang X; Wayne C; Wang X; Han L; Ye L; Zhao Q; Jiang G; Feng M
    Biotechnol Lett; 2016 May; 38(5):801-7. PubMed ID: 26830094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carboxyl-terminal region is a determinant for the intracellular behavior of the chorionic gonadotropin beta subunit: effects on the processing of the Asn-linked oligosaccharides.
    Muyan M; Boime I
    Mol Endocrinol; 1998 May; 12(5):766-72. PubMed ID: 9605938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
    Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
    Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human growth hormone-binding protein fails to enhance the in vivo bioactivity of human growth hormone in normal rats.
    Tzanela M; Wagner C; Tannenbaum GS
    Endocrinology; 1997 Dec; 138(12):5316-24. PubMed ID: 9389516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-chain bifunctional vascular endothelial growth factor (VEGF)-follicle-stimulating hormone (FSH)-C-terminal peptide (CTP) is superior to the combination therapy of recombinant VEGF plus FSH-CTP in stimulating angiogenesis during ovarian folliculogenesis.
    Trousdale RK; Pollak SV; Klein J; Lobel L; Funahashi Y; Feirt N; Lustbader JW
    Endocrinology; 2007 Mar; 148(3):1296-305. PubMed ID: 17122074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
    Bouloux PM; Handelsman DJ; Jockenhövel F; Nieschlag E; Rabinovici J; Frasa WL; de Bie JJ; Voortman G; Itskovitz-Eldor J;
    Hum Reprod; 2001 Aug; 16(8):1592-7. PubMed ID: 11473948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties of a novel follicle-stimulating hormone/human chorionic gonadotropin chimeric gonadotropin.
    Garone LM; Ammannati E; Brush TS; Fischer DJ; Tos EG; Luo J; Altobello KL; Ciampolillo C; Ihley TM; Kurosawa E; Tiebout A; McKenna S
    Endocrinology; 2006 Sep; 147(9):4205-12. PubMed ID: 16794004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat.
    Clark RG; Mortensen DL; Carlsson LM; Spencer SA; McKay P; Mulkerrin M; Moore J; Cunningham BC
    Endocrinology; 1996 Oct; 137(10):4308-15. PubMed ID: 8828490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit.
    Fares FA; Suganuma N; Nishimori K; LaPolt PS; Hsueh AJ; Boime I
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4304-8. PubMed ID: 1374895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.